Researchers have launched the nation’s first research consortium dedicated to studying paradoxical lucidity, a rare phenomenon where patients with advanced dementia unexpectedly regain clear-eyed communication. Led by Duke University neuroscientist Heather Elizabeth Whitson, the newly formed network aims to standardize definitions and uncover underlying brain mechanisms.
For decades, families and caregivers have witnessed a profound medical mystery: individuals in the advanced stages of Alzheimer’s disease or other forms of dementia, who may not have spoken in weeks or months, suddenly become lucid. These unexpected episodes of heightened awareness and cognitive function can last for minutes or hours before vanishing just as abruptly as they arrived.
The Lucidity in Alzheimer’s and Dementia Network Launch
–/wp:heading –>
To tackle this long-standing puzzle, researchers at Duke University are teaming up with colleagues at the University of Wisconsin and the Mayo Clinic. Headed by Heather Elizabeth Whitson — a neuroscientist and director of the Duke Center for the Study of Aging and Human Development — the newly established initiative is called the Lucidity in Alzheimer’s and Dementia Network, or LEAD.
Whitson, who also holds professorships in medicine, neurology, ophthalmology, and head and neck surgery and communication sciences at the Duke School of Medicine, co-directs the Duke/UNC Alzheimer’s Disease Research Center. Her multidisciplinary team brings together specialists from geriatrics, psychology, data science, measurement science, and neuroscience.
Three Core Goals of the LEAD Consortium
–/wp:heading –>
The newly formed consortium has outlined three primary objectives to guide its investigation into these fleeting moments of clarity.
- Developing a standard definition for lucidity and paradoxical lucidity.
- Understanding the impact that these sudden episodes have on families and caregivers.
- Uncovering the neural mechanisms responsible for making these clear-eyed periods possible.
Explaining the biological focus of the investigation, Whitson noted, We want to understand what is happening at the level of brain circuits, cells, and molecules.
Shifting the Focus From Brain Failure to Preserved Function
–/wp:heading –>
Much of the research strategy relies on inverting a fundamental premise. Instead of exclusively examining why the brain deteriorates and fails in neurodegenerative illness, investigators in the LEAD network hope to determine why a failing brain occasionally appears to briefly restore its functions.
We’ve spent decades focused on preventing dementia and treating dementia,
Whitson said, describing the shift in investigative perspective. This research asks a different question: What allows moments of preserved function to emerge, even in the setting of advanced disease?
